SMALL CELL LUNG CARCINOMA EXTENSIVE DISEASE

Clinical trials for SMALL CELL LUNG CARCINOMA EXTENSIVE DISEASE explained in plain language.

Never miss a new study

Get alerted when new SMALL CELL LUNG CARCINOMA EXTENSIVE DISEASE trials appear

Sign up with your email to follow new studies for SMALL CELL LUNG CARCINOMA EXTENSIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Major trial tests new drug combo to extend lives in aggressive lung cancer

Disease control Ongoing

This large, late-stage trial tested whether adding one or two immunotherapy drugs (durvalumab and tremelimumab) to standard chemotherapy could help patients with extensive-stage small cell lung cancer live longer. Nearly 1,000 adults with this advanced cancer were randomly assign…

Matched conditions: SMALL CELL LUNG CARCINOMA EXTENSIVE DISEASE

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

SMALL CELL LUNG CARCINOMA EXTENSIVE DISEASE

Get alerted when new SMALL CELL LUNG CARCINOMA EXTENSIVE DISEASE trials appear

Major trial tests new drug combo to extend lives in aggressive lung cancer